Universal Cells is a Seattle-based brand that specializes in producing engineered stem cell lines for allogeneic cell therapy treatments. Their goal is to create stem cells that can avoid rejection and provide therapies for patients in need. With their motto of One Cell, Many Therapies, Universal Cells aims to revolutionize the field of regenerative medicine.

Led by a team of experienced professionals, including President and Chief Intelligence Officer Noboru Yamaji, Ph. D., Associate Director Tamar Boursalian, Ph. D., and Director of Research Ryan Davis, Ph.

D., Universal Cells combines expertise in immunology, oncology, and gene editing to develop innovative treatments. Their services also include clinical gene editing, NK cell biology, and process development. Universal Cells was founded by Dr.

David Russell, an esteemed researcher and professor, and is built upon cutting-edge gene-editing and immune rejection technologies. This brand is dedicated to improving the lives of patients and advancing the field of regenerative medicine